Home › NCT07155057

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

A Prospective, Single-Arm Study Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of Dry Eye Disease in Patients Undergoing Refractive Cataract Surgery

Who can join

Ages 22 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Be willing and able to understand and sign the informed consent form (ICF)
* Men or non-pregnant women age 22 or older
* Clear intraocular media other than cataract
* Diagnosis of dry eye disease (OSDI score ≥ 13)
* Non-invasive Tear break up time ≤ 10 seconds in at least one eye
* Willing and able to comply with all study related visits and procedures
* In the opinion of the investigator, patients who are appropriate for advanced technology lens implants

Exclusion Criteria:

* History of punctal cautery
* Lacrimal anatomy (e.g., nasolacrimal duct obstruction) that per investigator suggests that the patient would not be a good candidate for lacrimal occlusion or patients for whom lacrimal occlusion would increase risk

About the study

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

What is being tested

• Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML (device)

Sponsor: Vance Thompson Vision · Participants: 60 · Started: Sep 3, 2025

Contact the study team

• Tiffany Facile · Phone: 605-371-7075

Official record on ClinicalTrials.gov — NCT07155057

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.